Drug search by name

Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic and Myasthenia gravis

Result of checking the interaction of drug Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic and disease Myasthenia gravis for safety when used together.

Check result:

Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic <> Myasthenia gravis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Because antimuscarinic agents have anticholinergic effects, they are contraindicated in patients with myasthenia gravis. Their use may be appropriate to reduce adverse muscarinic effects caused by an anticholinesterase agent.

References:

"Product Information. Atropine Sulfate Injection, USP (atropine)." ESI Lederle Generics, Philadelphia, PA.
Shutt LE, Bowes JB "Atropine and hyoscine." Anaesthesia 34 (1979): 476-90

Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic

Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate

Brand Name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA

Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate

What is Hyoscyamine, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic?